“紫杉醇脂体与紫杉醇联合卡铂在卵巢癌一线化疗中的疗效和安全性:一项多中心、开放标签、非劣效性、随机对照试验”的勘误表[Journal of the National cancer Center 4 (2024) 135-141]

IF 7.6 Q1 ONCOLOGY
Rong Li , Hongping Zhang , Qingshui Li , Guangwen Yuan , Yanjie Zhou , Rutie Yin , He Wang , Chunyan Wang , Yi Huang , Wei Wang , Xiaojian Yan , Lingying Wu , Qi Zhou
{"title":"“紫杉醇脂体与紫杉醇联合卡铂在卵巢癌一线化疗中的疗效和安全性:一项多中心、开放标签、非劣效性、随机对照试验”的勘误表[Journal of the National cancer Center 4 (2024) 135-141]","authors":"Rong Li , Hongping Zhang , Qingshui Li , Guangwen Yuan , Yanjie Zhou , Rutie Yin , He Wang , Chunyan Wang , Yi Huang , Wei Wang , Xiaojian Yan , Lingying Wu , Qi Zhou","doi":"10.1016/j.jncc.2024.11.002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73987,"journal":{"name":"Journal of the National Cancer Center","volume":"5 1","pages":"Page 93"},"PeriodicalIF":7.6000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to ‘Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial’ [Journal of the National Cancer Center 4 (2024) 135–141]\",\"authors\":\"Rong Li , Hongping Zhang , Qingshui Li , Guangwen Yuan , Yanjie Zhou , Rutie Yin , He Wang , Chunyan Wang , Yi Huang , Wei Wang , Xiaojian Yan , Lingying Wu , Qi Zhou\",\"doi\":\"10.1016/j.jncc.2024.11.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":73987,\"journal\":{\"name\":\"Journal of the National Cancer Center\",\"volume\":\"5 1\",\"pages\":\"Page 93\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the National Cancer Center\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667005424001121\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Center","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667005424001121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本文章由计算机程序翻译,如有差异,请以英文原文为准。
Corrigendum to ‘Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial’ [Journal of the National Cancer Center 4 (2024) 135–141]
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
14.20
自引率
0.00%
发文量
0
审稿时长
70 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信